Alan E. Levine

1.2k total citations
36 papers, 1.0k citations indexed

About

Alan E. Levine is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Alan E. Levine has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Alan E. Levine's work include TGF-β signaling in diseases (11 papers), Aldose Reductase and Taurine (5 papers) and Peptidase Inhibition and Analysis (5 papers). Alan E. Levine is often cited by papers focused on TGF-β signaling in diseases (11 papers), Aldose Reductase and Taurine (5 papers) and Peptidase Inhibition and Analysis (5 papers). Alan E. Levine collaborates with scholars based in United States, Germany and India. Alan E. Levine's co-authors include Michael G. Brattain, Diane E. Brattain, Mary K. McKnight, Kenneth A. Walsh, Lynn C. Yeoman, Naseema M. Hoosein, Kathleen M. Mulder, B H Long, Samit Chakrabarty and James K. V. Willson and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Bioinformatics.

In The Last Decade

Alan E. Levine

35 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan E. Levine United States 18 663 427 165 149 85 36 1.0k
P Selvanayagam United States 17 610 0.9× 355 0.8× 65 0.4× 124 0.8× 58 0.7× 32 1.1k
Teresa Petrocelli Canada 9 951 1.4× 534 1.3× 181 1.1× 97 0.7× 106 1.2× 11 1.4k
Erwin T. Waas Netherlands 9 629 0.9× 355 0.8× 381 2.3× 67 0.4× 86 1.0× 11 1.1k
Muriel D. David France 20 851 1.3× 283 0.7× 197 1.2× 39 0.3× 92 1.1× 26 1.5k
J P Witty United States 11 456 0.7× 430 1.0× 494 3.0× 58 0.4× 101 1.2× 11 1.0k
Steven Bossone United States 7 985 1.5× 234 0.5× 121 0.7× 70 0.5× 142 1.7× 8 1.2k
Daniel S. Liscia United States 18 641 1.0× 564 1.3× 259 1.6× 170 1.1× 224 2.6× 32 1.1k
José F. Ruiz Spain 17 1.0k 1.5× 171 0.4× 377 2.3× 66 0.4× 158 1.9× 29 1.4k
Akinori Yoda Japan 19 938 1.4× 404 0.9× 173 1.0× 126 0.8× 165 1.9× 32 1.4k
Ingrid B.J. Joseph United States 17 565 0.9× 315 0.7× 245 1.5× 38 0.3× 137 1.6× 40 1.2k

Countries citing papers authored by Alan E. Levine

Since Specialization
Citations

This map shows the geographic impact of Alan E. Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan E. Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan E. Levine more than expected).

Fields of papers citing papers by Alan E. Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan E. Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan E. Levine. The network helps show where Alan E. Levine may publish in the future.

Co-authorship network of co-authors of Alan E. Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Alan E. Levine. A scholar is included among the top collaborators of Alan E. Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan E. Levine. Alan E. Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levine, Alan E.. (2011). Correlation between Clicker Scores and Examination Performance in Dental Biochemistry. Medical Science Educator. 21(4). 326–329. 4 indexed citations
2.
Levine, Alan E.. (2001). OrCGDB: a database of genes involved in oral cancer. Nucleic Acids Research. 29(1). 300–302. 35 indexed citations
3.
Steffen, David L., et al.. (2000). Digital reviews in molecular biology: approaches to structured digital publication. Bioinformatics. 16(7). 639–649. 6 indexed citations
4.
Maruvada, Padma & Alan E. Levine. (1999). Increased transforming growth factor-? levels in human colon carcinoma cell lines over-expressing protein kinase C. International Journal of Cancer. 80(1). 72–77. 14 indexed citations
5.
Lu, Haiquan, Ian C. Mackenzie, & Alan E. Levine. (1997). Transforming growth factor‐β response and expression in junctional and oral gingival epithelial cells. Journal of Periodontal Research. 32(8). 682–691. 17 indexed citations
6.
Ramesh, G. & Alan E. Levine. (1995). Pro‐transforming growth factor‐alpha processing in human colon carcinoma cells: Role of protein kinase C. International Journal of Cancer. 62(4). 492–497. 7 indexed citations
7.
8.
Levine, Alan E., et al.. (1993). Transforming growth factor-β2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line. Cancer Letters. 68(1). 33–41. 7 indexed citations
9.
Levine, Alan E., et al.. (1992). Sodium butyrate alters the response of a human colon carcinoma cell line to transforming growth factor-β1. Cancer Letters. 63(1). 33–40. 5 indexed citations
10.
Levine, Alan E. & Subhas Chakrabarty. (1992). Response of FR3T3 cells transformed by HA‐ras oncogene and epidermal growth factor gene to differentiation induction by N,N‐dimethylformamide. International Journal of Cancer. 50(4). 653–658. 6 indexed citations
11.
Levine, Alan E., et al.. (1991). Differential role of transforming growth factor‐α in two human colon‐carcinoma cell lines. International Journal of Cancer. 47(3). 455–460. 24 indexed citations
12.
Levine, Alan E., et al.. (1990). Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. International Journal of Cancer. 45(2). 372–375. 88 indexed citations
13.
Levine, Alan E., et al.. (1989). Effects of N,N‐dimethylformamide and extracellular matrix on transforming growth factor‐β binding to a human colon carcinoma cell line. Journal of Cellular Physiology. 138(3). 459–466. 10 indexed citations
14.
Hoosein, Naseema M., Mary K. McKnight, Alan E. Levine, et al.. (1989). Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-β1. Experimental Cell Research. 181(2). 442–453. 124 indexed citations
15.
Mulder, Kathleen M., et al.. (1988). Modulation of C-myc by transforming growth factor-β in human colon carcinoma cells. Biochemical and Biophysical Research Communications. 150(2). 711–716. 52 indexed citations
16.
Brattain, Michael G., et al.. (1988). Modulation of a high molecular weight form of transforming growth factor-α in human colon carcinoma cell lines. Cancer Letters. 40(1). 59–70. 27 indexed citations
17.
Mulder, Katrien De, et al.. (1986). Effect of differentiation agents on C-MYC expression in transformed fibroblasts and in human colon carcinoma cells. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 1 indexed citations
18.
Levine, Alan E., et al.. (1986). Retinoic acid restores normal growth control to a transformed mouse embryo fibroblast cell line. Cancer Letters. 33(1). 33–43. 10 indexed citations
19.
Levine, Alan E., et al.. (1985). Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line.. PubMed. 45(5). 2248–54. 24 indexed citations
20.
Levine, Alan E., et al.. (1985). Changes in receptor occupancy and growth factor responsiveness induced by treatment of a transformed mouse embryo cell line with N,N-dimethylformamide.. PubMed. 45(12 Pt 1). 6401–5. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Selvanayagam Breakdown of academic impact, for papers by Teresa Petrocelli Breakdown of academic impact, for papers by Erwin T. Waas Breakdown of academic impact, for papers by Muriel D. David Breakdown of academic impact, for papers by J P Witty Breakdown of academic impact, for papers by Steven Bossone Breakdown of academic impact, for papers by Daniel S. Liscia Breakdown of academic impact, for papers by José F. Ruiz Breakdown of academic impact, for papers by Akinori Yoda Breakdown of academic impact, for papers by Ingrid B.J. Joseph
Rankless by CCL
2026